Sources

4 Total Sources

DT-109 Reverses Severe MASH in Animals by Repairing Gut Barrier, Targeting Disease Affecting 7%

ScienceDaily10h ago

Experimental Drug DT-109 Reverses Severe Fatty Liver Disease (MASH) in Animals by Repairing Gut

Michigan Medicine Scientists Develop DT-109 Drug to Repair MASH Liver Damage via Gut Health

Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis | Science Translational Medicine

National Institutes of Health (NIH) (.gov)1d ago

Taming fatty liver: can taurine combat metabolic dysfunction in MASLD? - PMC